Astrid Borkowski - 28 Apr 2022 Form 3 Insider Report for HilleVax, Inc. (HLVX)

Role
Chief Medical Officer
Signature
/s/ Paul Bavier, Attorney-in-fact
Issuer symbol
HLVX
Transactions as of
28 Apr 2022
Net transactions value
$0
Form type
3
Filing time
28 Apr 2022, 21:45:29 UTC
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HLVX Common Stock 168,100 28 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of restricted stock subject to repurchase by the Issuer.

Remarks:

Exhibit 24 - Power of Attorney.